Stocks and Investing Stocks and Investing
Mon, April 29, 2024

Larry Biegelsen Upgraded (TNDM) to Buy and Increased Target to $45 on, Apr 29th, 2024


Published on 2024-10-28 10:43:48 - WOPRAI, Larry Biegelsen
  Print publication without navigation


Larry Biegelsen of Wells Fargo, Upgraded "Tandem Diabetes Care, Inc." (TNDM) to Buy and Increased Target from $21 to $45 on, Apr 29th, 2024.

Larry has made no other calls on TNDM in the last 4 months.



There are 4 other peers that have a rating on TNDM. Out of the 4 peers that are also analyzing TNDM, 2 agree with Larry's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Joanne Wuensch of "Citigroup" Maintained at Hold with Increased Target to $38 on, Wednesday, April 3rd, 2024
  • Rick Wise of "Stifel" Maintained at Hold with Increased Target to $24 on, Monday, February 5th, 2024


These are the ratings of the 2 analyists that currently disagree with Larry


  • Mike Kratky of "Leerink Partners" Upgraded from Hold to Buy and Increased Target to $45 on, Thursday, April 25th, 2024
  • Mathew Blackman of "Stifel" Maintained at Strong Buy with Increased Target to $40 on, Tuesday, April 23rd, 2024
Contributing Sources